Gensight Biologics SA

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: FR0013183985
EUR
0.09
0 (-2.84%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
OSE Immunotherapeutics SA
Cellectis SA
Sensorion SA
Genfit SA
Adocia SA
MedinCell SA
Maat Pharma SA
Innate Pharma SA
ABIONYX Pharma SA
Gensight Biologics SA
Valerio Therapeutics SA

Why is Gensight Biologics SA ?

Icon
Unrated Stock - No Analysis Available
stock-recommendationReal-Time Research Report

Verdict Report

Icon
No Data Found

Is Gensight Biologics SA for you?

High Risk, Low Return

Absolute
Risk Adjusted
Volatility
Gensight Biologics SA
-62.17%
-1.00
97.45%
France CAC 40
0.34%
-0.10
17.53%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
3.54%
EBIT Growth (5y)
10.33%
EBIT to Interest (avg)
-18.86
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.42
Sales to Capital Employed (avg)
0.03
Tax Ratio
7.31%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
-0.62
EV to EBIT
-2.11
EV to EBITDA
-2.19
EV to Capital Employed
-1.82
EV to Sales
33.67
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
Negative BV
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bullish
RSI
Bullish
Bullish
Bollinger Bands
Mildly Bearish
Mildly Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Bearish
Dow Theory
No Trend
Bearish
OBV
No Trend
Mildly Bearish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

3What is working for the Company
RAW MATERIAL COST(Y)

Fallen by 0% (YoY

OPERATING PROFIT(Q)

Highest at EUR -6.96 MM

EPS(Q)

Highest at EUR -0.05

-1What is not working for the Company
INTEREST(Q)

Highest at EUR 2.17 MM

Here's what is working for Gensight Biologics SA

Operating Profit
Highest at EUR -6.96 MM
in the last five periods
MOJO Watch
Near term Operating Profit trend is positive

Operating Profit (EUR MM)

EPS
Highest at EUR -0.05
in the last five periods
MOJO Watch
Increasing profitability; company has created higher earnings for shareholders

EPS (EUR)

Raw Material Cost
Fallen by 0% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Gensight Biologics SA

Interest
Highest at EUR 2.17 MM
in the last five periods and Increased by 7.27% (QoQ)
MOJO Watch
Rising interest cost signifies increased borrowings

Interest Paid (EUR MM)